New evidence, new guidelines, and new criteria for secondary prevention of ischemic stroke / 中华神经科杂志

ABSTRACT

Ischemic stroke and transient ischemic attack (TIA) are the most common subtypes of cerebrovascular diseases. Effective secondary prevention is an important approach to reduce the risk of stroke recurrence, disability, and mortality. With the development of international and domestic clinical research on the secondary prevention of ischemic stroke and TIA, new evidence-based medical evidence has been present, especially evidence in risk factor control, antithrombotic therapy, and other treatments. Based on these findings, the guidelines were updated in a timely and systematic manner to provide new standard of secondary prevention for stroke patients.